Immediate results of percutaneous management of coarctation of the aorta: A 7-year single-centre experience

BackgroundCoarctation of the aorta (CoA) is often treated percutaneously. The aim this study was to describe immediate results percutaneous management native aortic coarctation (NaCoA) and recoarctation (ReCoA) at our institution.MethodsWe identified all patients with NaCoA or ReCoA who underwent dilatation by either balloon angioplasty (BAP) endovascular stent implantation (ESI) between 2011 2017. Success defined as a residual peak-to-peak gradient (PPG) <20 mmHg ?50% reduction in if pre-intervention PPG mmHg.Results63 (median age 6.8 years, interquartile range [IQR] 0.4–14.2) were identified. Among 11 NaCoA, 7 BAP 4 had ESI, among 52 ReCoA, 42 10 ESI. In successful 71%, median decreasing from 32 (IQR 25–46) 17 4–23) (p = .02), ESI 100%, 20 14.5–40) 2 0–6) < .01). 69%, 16–31.3) 9 0–14.3) .001), 18 11.5–22.8) 0 0–3.5) more than There only one complication.ConclusionsPercutaneous CoA safe effective both ReCoA. Stent BAP.